Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSV | O60911 | 3/20 | 0.81 |
| ▸ | CTSL | P07711 | 3/20 | 0.81 |
| ▸ | AKR1C3 | P42330 | 6/20 | 0.65 |
| ▸ | AKR1C2 | P52895 | 6/20 | 0.65 |
| ▸ | MAPT | P10636 | 5/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.62 |
| ▸ | MEN1 | O00255 | 4/20 | 0.62 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.60 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.60 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.60 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.60 |
| ▸ | MYC | P01106 | 1/20 | 0.60 |
| ▸ | MAX | P61244 | 1/20 | 0.60 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.58 |
| ▸ | ANO2 | Q9NQ90 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | GFER | P55789 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2920267 | 0.91 | CTSV (0.69) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL16737173 | 0.90 | CTSV (0.82) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL7331118 | 0.90 | CTSV (1.00) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL3033026 | 0.89 | CTSV (0.76) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL16737119 | 0.88 | CTSV (0.79) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL16737146 | 0.86 | CTSV (0.65) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL16737153 | 0.86 | CTSV (0.65) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL22720113 | 0.85 | MEN1 (0.72) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL10652234 | 0.85 | AKR1C3 (0.63) | CTSVCTSLAKR1C3AKR1C2MAPT | |
| SCHEMBL9094091 | 0.83 | AKR1C3 (0.82) | CTSVCTSLAKR1C3AKR1C2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12545651-B2 | Diphenylamine-linked chiral bis(oxazoline) ligand without C2-symmetry, synthesis method and application thereof | ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) | 2026-02-10 | — | — | US | disclosed |
| US-20220227719-A1 | A diphenylamine-linked chiral bis(oxazoline) ligand without C2-symmetry, synthesis method and application thereof | ZHEJIANG UNIVERSITY OF TECHNOLOGY (CN) | 2022-07-21 | — | — | US | disclosed |
| CN-110229114-B | Remove C2-toSymmetric diphenylamine type chiral bisoxazoline ligand and synthetic method and application thereof | 浙江工业大学 | 2021-07-27 | — | — | CN | disclosed |
| WO-2020238559-A1 | DE-C2-SYMMETRIC DIPHENYLAMINE-TYPE CHIRAL BISOXAZOLINE LIGAND, SYNTHESIS METHOD THEREFOR AND USE THEREOF | 浙江工业大学 | 2020-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220227719-A1 | A diphenylamine-linked chiral bis(oxazoline) ligand without C2-symmetry, synthesis method and application thereof | AOC1, AOC2, AOC3 | CTSV 3526/4885CTSL 3990/4885AKR1C3 306/4885 |
| US-12545651-B2 | Diphenylamine-linked chiral bis(oxazoline) ligand without C2-symmetry, synthesis method and application thereof | AOC2, AOC1, AOC3 | CTSV 4064/4885CTSL 4552/4885AKR1C3 108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.